Rehabilitation Management of Peripheral Neuropathy

Gregory T. Carter

doi:10.1055/s-2005-871331

Seminars in Neurology, Inhaltsverzeichnis

Semin Neurol 2005; 25(2): 229-237
DOI: 10.1055/s-2005-871331

Rehabilitation Management of Peripheral Neuropathy

Gregory T. Carter¹

¹Department of Rehabilitation Medicine, University of Washington, School of Medicine, Seattle, Washington

Abstract

ABSTRACT

The goals of rehabilitation for patients with peripheral neuropathy are to maximize and prolong independent and safe locomotion and function, inhibit physical deformity, and provide access to full integration into society. The services of multiple disciplines are required to fully achieve these goals and include physicians, nurses, therapists, orthotists, social and vocational counselors, and psychologists. Treatment is goal-oriented, using various modalities including exercise, bracing, adaptive equipment, medication, and surgery.

KEYWORDS

Peripheral neuropathy - rehabilitation - neuropathic pain - orthotics - neuromuscular disease

Volltext

Referenzen

REFERENCES

1 Emery A H. Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord. 1991; 1 19-29
2 Carter G T, Abresch R T, Fowler W M et al.. Profiles of neuromuscular disease: hereditary motor and sensory neuropathy, types I and II. Am J Phys Med Rehabil. 1995; 74 S140-S149
3 Carter G T. Neuromuscular disorders. In: Dell Orto AE, Marinelli RP Encyclopedia of Disability and Rehabilitation. New York; Simon & Schuster MacMillan 1995: 509-515
4 Fowler W M, Abresch R T, Aitkens S A, Carter G T. Impairment and disability profiles of neuromuscular diseases: design of the protocol. Am J Phys Med Rehabil. 1995; 74 62-69
5 Fowler W M, Carter G T, Kraft G H. Role of physiatry in the management of neuromuscular disease. Phys Med Rehabil Clin N Am. 1998; 9 1-8
6 Carter G T. e-Medicine: rehabilitation management of neuromuscular disease. Physical Medicine and Rehabititation. http://Available at: www.emedicine.com/pmr/topic 233.htm
7 Carter G T, England J D, Hecht T W, Han J, Weydt P, Chance P. Electrodiagnosis of hereditary motor and sensory neuropathies. Phys Med Rehabil Clin N Am. 2003; 14 347-363
8 Carter G T, England J D, Chance P F. Charcot-Marie-Tooth disease: electrophysiology, molecular biology, and clinical management. IDrugs. 2004; 7 151-159
9 Ionasescu V V. Charcot-Marie-Tooth neuropathies: from clinical description to molecular genetics. Muscle Nerve. 1995; 18 267-275
10 Lindeman E, Leffers P, Reulen J, Spaans F, Drukker J. Quadriceps strength and timed motor performances in myotonic dystrophy, Charcot-Marie-Tooth disease, and healthy subjects. Clin Rehabil. 1998; 12 127-135
11 Lindeman E, Leffers P, Reulen J et al.. Reduction of knee torques and leg-related functional abilities in hereditary motor and sensory neuropathy. Arch Phys Med Rehabil. 1994; 75 1201-1205
12 Kilmer D D, Aitkens S G, Wright N C et al.. Simulated work performance tasks in persons with neuropathic and myopathic weakness. Arch Phys Med Rehabil. 2000; 81 938-943
13 Aitkens S G, McCrory M A, Kilmer D D, Bernauer E M. Moderate resistance exercise program: its effects in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1993; 74 711-715
14 Kilmer D D, McCrory M A, Wright N C, Aitkens S G, Bernauer E M. The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1994; 75 560-563
15 Kilmer D D. Response to aerobic exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil. 2002; 81 S148-S150
16 Kilmer D D. Response to resistive strengthening exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil. 2002; 81 S121-S126
17 Kilmer D D. The role of exercise in neuromuscular disease. Phys Med Rehabil Clin N Am. 1998; 9 115-125
18 Lindeman E, Leffers P, Spaans F et al.. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil. 1995; 76 612-620
19 Kilmer D D, Mcrory M A, Wright N C et al.. Hand held dynamometry reliability in persons with neuropathic weakness. Arch Phys Med Rehabil. 1997; 78 1364-1368
20 Carter G T, Kikuchi N, Abresch R T, Walsh S A, Horasek S, Fowler W M. Effects of exhaustive concentric and eccentric exercise on murine skeletal muscle. Arch Phys Med Rehabil. 1994; 75 555-559
21 Carter G T, Abresch R T, Fowler W M. Adaptations to exercise training and contraction-induced muscle injury in animal models of neuromuscular disease. Am J Phys Med Rehabil. 2002; 81(suppl) S151-S161
22 Breslin E, Booth J, Lord B et al.. Respiratory responses to unsupported arm exercise (UAE) in Charcot Marie Tooth (CMT) [abstract]. American Thoracic Society. Am Rev Respir Dis. 1993; 147 532A
23 Breslin E H, Carter G T, Mercer K, Bonekat H W, Lee K. Fatigue in patients with Charcot-Marie-Tooth [abstract]. Arch Phys Med Rehabil. 1993; 74 A1256-A1257
24 Videler A J, Beelen A, Aufdemkampe G et al.. Hand strength and fatigue in patients with hereditary motor and sensory neuropathy (types I and II). Arch Phys Med Rehabil. 2002; 83 1274-1278
25 Carter G T, Kilmer D D, Szabo R M, McDonald C M. Focal posterior interosseus neuropathy in the presence of hereditary motor and sensory neuropathy, type I. Muscle Nerve. 1996; 19 644-648
26 McDonald C M. Limb contracture in progressive neuromuscular disease and the role of stretching, orthotics, and surgery. Phys Med Rehabil Clin N Am. 1998; 9 187-212
27 Paulson L E, Kilmer D D. Orthotic management in peripheral neuropathy. Phys Med Rehabil Clin N Am. 2001; 12 433-445
28 Boninger M L, Leonard Jr J A. Use of bivalved ankle-foot orthosis in neuropathic foot and ankle lesions. J Rehabil Res Dev. 1996; 33 16-19
29 Bean J, Walsh A, Frontera W. Brace modification improves aerobic performance in Charcot-Marie-Tooth disease: a single-subject design. Am J Phys Med Rehabil. 2001; 80 578-582
30 Perry J. Normal and pathological gait. In: Goldberg B, Hsu JD Atlas of Orthoses and Assistive Devices. 3rd ed. St. Louis; Mosby 1997: 295-304
31 Helm P A, Walker S C, Pullium G. Total contact casting in diabetics with neuropathic foot ulcerations. Arch Phys Med Rehabil. 1984; 65 691-695
32 Helm P A, Walker S C, Pullium G F. Recurrence of neuropathic ulceration following healing in a total contact cast. Arch Phys Med Rehabil. 1991; 72 967-975
33 King S, Thomas J J, Rice M S. The immediate and short-term effects of a wrist extension orthosis on upper-extremity kinematics and range of shoulder motion. Am J Occup Ther. 2003; 57 517-524
34 Schon L C, Easley M E, Weinfeld S B. Charcot neuroarthropathy of the foot and ankle. Clin Orthop. 1998; 349 116-117
35 Sella E J, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg. 1999; 38 34-45
36 Sinacore D R, Withrington N C. Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle. J Orthop Sports Phys Ther. 1999; 29 736-741
37 Walker S C, Helm P A, Pullium G. Total contact casting and chronic diabetic neuropathic foot ulcerations: healing rates by wound location. Arch Phys Med Rehabil. 1987; 68 217-223
38 Mehta J A, Brown C, Sargeant N. Charcot restraint orthotic walker. Foot Ankle Int. 1998; 19 619-624
39 Morgan J M, Biehl III W C, Wagner F W. Management of neuropathic arthropathy with the Charcot Restraint Orthotic Walker. Clin Orthop. 1993; 296 58-64
40 Carter G T, Jensen M P, Galer B S et al.. Neuropathic pain in Charcot Marie Tooth disease. Arch Phys Med Rehabil. 1998; 79 1560-1564
41 Moulin D E, Hagen N, Feasby T E, Amireh R, Hahn A. Pain in Guillain-Barre syndrome. Neurology. 1997; 48 328-331
42 Carter G T, Galer B S. Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am. 2001; 12 447-460
43 Abresch R T, Jensen M P, Carter G T. Health quality of life in peripheral neuropathy. Phys Med Rehabil Clin N Am. 2001; 12 461-472
44 Abresch R T, Carter G T, Jensen M P, Kilmer D D. Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hosp Palliat Care. 2002; 19 39-48
45 Backonja M M. Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus. Epilepsia. 1999; 40 S57-S59
46 Beydoun A. Postherpetic neuralgia: role of gabapentin and other treatment modalities. Epilepsia. 1999; 40 S51-S56
47 Magnus L. Nonepileptic uses of gabapentin. Epilepsia. 1999; 40 S66-S72
48 McQuay H, Carroll D, Jadad A R et al.. Anticonvulsant drugs for management of pain: a systemic review. BMJ. 1995; 311 1047-1052
49 Morello C M, Leckband S G, Stoner C P et al.. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med. 1999; 159 1931-1937
50 Carter G T, Sullivan M D. Antidepressants in pain management. Curr Opin Investig Drugs. 2002; 3 454-458
51 Kingery W S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 1997; 73 123-139
52 Max M B, Culnane M, Schafer S C et al.. Amitriptyline relieves diabetic neuropathy pain in patients with normal depressed mood. Neurology. 1987; 37 589-596
53 Max M B, Lynch S A, Muir J et al.. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992; 326 1250-1252
54 Watson C P, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology. 1998; 51 1166-1171
55 Taylor K, Rowbotham M C. Venlafaxine hydrochloride and chronic pain. West J Med. 1996; 165 147-148
56 Galer B S, Harle J, Rowbotham M C. Response to intravenous lidocaine infusion predicts subsequent response to oral mexilitine: a prospective study. J Pain Symptom Manage. 1996; 12 161-167
57 Galer B S, Miller K V, Rowbotham M C. Response to intravenous lidocaine differs based on clinical diagnosis and site of nervous system injury. Neurology. 1993; 43 1233-1235
58 Galer B S. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology. 1995; 45 17-25
59 Galer B S, Rowbotham M C, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle patch: results of an enriched enrollment study. Pain. 1999; 80 533-538
60 Galer B S. Painful polyneuropathy. Neurol Clin. 1998; 16 791-812
61 Duhmke R M, Cornblath D D, Hollingshead J R. Tramadol for neuropathic pain. Cochraine Database Syst Rev. 2004; (2) CD003726
62 Watson C P, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998; 50 1837-1841
63 Jay C, Shade S, Vizoso H et al.. The effect of smoked marijuana on chronic neuropathic and experimentally induced pain in HIV neuropathy: results of an open-label pilot study. Proceedings of the 11th Conference on Retroviruses and Opportunistic Infections. 2004 496: A243 (Abstract)
64 Wade D T, Robson P, House H, Makela P, Aram J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil. 2003; 17 21-29
65 Carter G T, Rosen B S. Marijuana in the management of amyotrophic lateral sclerosis. Am J Hosp Palliat Care. 2001; 18 264-270
66 Carter G T, Weydt P. Cannabis: old medicine with new promise for neurological disorders. Curr Opin Investig Drugs. 2002; 3 437-440
67 Robson P. Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry. 2001; 178 98-105
68 Rice A SC. Cannabinoids and pain. Curr Opin Investig Drugs. 2001; 2 399-414

Gregory T CarterM.D.

1809 Cooks Hill Road

Centralia, WA 98531